OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
August 28, 2017
High-priority issues requiring immediate attention leave little time for Congress to consider drug access proposals that have limited bipartisan support.
August 10, 2017
Efforts to establish an international system for identifying and tracing drugs through the global supply chain are moving forward.
August 08, 2017
The Senate voted 94–1 to approve legislation reauthorizing user fees and a series of program changes.
August 02, 2017
FDA urges manufacturers to seek fast approval of “high-need” generics and targeted therapies.
July 28, 2017
Manufacturers are seeking greater oversight of how providers reimburse for and dispense covered drugs.
July 02, 2017
CDER’s Janet Woodcock endorses modern drug manufacturing to ensure access to safe and reliable medicines.